The Mechanisms for Erythropoietin's Neovascularization Promotion

Dafan Yu,Li Jiang,Lihua Zhu
DOI: https://doi.org/10.1166/jnn.2016.12978
2016-01-01
Journal of Nanoscience and Nanotechnology
Abstract:Erythropoietin is an acidic glycoprotein cytokine that is well known for its positive effect on bone marrow hematopoiesis and neovascularization. The erythropoietin gene is the target gene for hypoxia inducible factor and hypoxia activates the hypoxia inducible factor 1 pathway to upregulate erythropoietin transcription. The Erythropoietin activates JAK2, STAT, PI3K/AKT and ERK1/2 by phosphorylation to induce the neovascularization via its receptor. The existing paracrine/autocrine erythropoietin loop enhances its functions on one hand while it can induce target cells to secrete cytokines, matrix metalloproteinases and integrin for augmenting neovascularization. Briefly, the erythropoietin can promote proliferation, differentiation, and tube formation capability of endothelial cells. It can also promote maturation of neovascularization by direct cellular effects and indirect humoral effects. Although the erythropoietin can promote neovascularization, its high dose use induces hematological adverse reactions. Epo-loaded oligochitosan nanoparticles and certain erythropoietin derivatives have currently shown promise in promoting neovascularization, because they produce less hematological adverse reactions. This review therefore discusses the molecular mechanisms on how the erythropoietin promotes neovascularization.
What problem does this paper attempt to address?